Characterization of Key Epigenetic Targets in Hepatic Fibrosis and Hepatocellular Carcinoma Development. Generation of New Antifibrotic and Antitumoral Drugs.

Norman Wolmark

NRG Oncology Network Group Operations Center

Liver and intrahepatic bile ducts

Radiation Oncology Surgery / Surgical oncology

Jian-Min Yuan

Prospective Studies of Cancer Etiology and Prevention in Shanghai and Singapore

Liver and intrahepatic bile ducts

Pathology

Charles D Blanke

SWOG Network Group Operations Center of the NCTN

Liver and intrahepatic bile ducts

Fiona Fennessy

Multidisciplinary Training In Image Guided Therapy

Prostate Liver and intrahepatic bile ducts Kidney, renal pelvis and ureter Brain, nervous system

Jean-Francois H Geschwind

See, Reach, Treat Tumor-Optimized Transarterial Chemoembolization DrugDelivery

Liver and intrahepatic bile ducts

Pathology

David J Waxman

Regulation of Sex Differences in Liver Metabolism

Liver and intrahepatic bile ducts

John Tavis

N-hydroxyisoquinolinediones as HCC Preventatives

Liver and intrahepatic bile ducts

Pathology

Robert F Schwabe

Hepatic Stellate Cells and Liver Cancer

Liver and intrahepatic bile ducts

Pathology

Paul J Brindley

Biomarkers of Opisthorchis Viverrini-Induced Cholangiocarcinoma

Liver and intrahepatic bile ducts

Pathology